TARO Taro Pharmaceutical Industries Ltd.

Taro to Announce Second Quarter Results on November 7, 2017

HAWTHORNE, N.Y.--(BUSINESS WIRE)--

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("TARO" or the "Company") announced today that it plans to release its financial results for the quarter and six months ended September 30, 2017, on Tuesday, November 7, 2017.

The Company will conduct an earnings call at 8:00 am EST on Wednesday, November 8, 2017, where senior management will discuss the Company’s performance and answer questions from participants.

The release will be accessible on Taro’s website at www.taro.com.

Earnings Call (8:00 am EST on Wednesday, November 8, 2017)

To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.

Summary of events

Event Date and time   Telephone number/ website
Earnings release November 7, 2017 (AMC)  

www.taro.com

Earnings conference call

8:00 am EST

November 8, 2017

 

Participant Toll-Free Dial-In Number: +1 (844) 421-0601

Participant International Dial-In Number: +1 (716) 247-5800

ID: 4298818

 

Via audio webcast, details of which will be made available on www.taro.com

Replay of conference call November 8, 2017 to

November 30, 2017

 

+ 1 (855) 859-2056 or +1 (404) 537-3406

ID: 4298818

 

Via audio webcast playback, details of which will be made available on www.taro.com

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

EN
30/10/2017

Underlying

TAROTaro Pharmaceutical Industries Ltd.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Taro Pharmaceutical Industries Ltd.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 48.00
VAC Marriott Vacati...
WWW Wolverine World... ... (+18)

Vermilion Compass: Weekly Equity Strategy

U.S. Dollar (DXY) Rolling Over Large-cap indexes (S&P 500, Nasdaq 100, and DJI) remain bullish, all hitting new all-time highs last week while continuing to find short-term support at their respective 20-day MAs. Mid-caps (S&P 400, Russell Mid-Cap) are starting another leg higher following breakouts from 2-month consolidations. Small-caps (S&P 600, Russell 2000) are likely to follow in the footsteps of large- and mid-caps, and are likely to break out from their 2.5-month consolidations/high bas...

VAC MARRIOTT VACATIONS WORLDWIDE CORPORATION
WWW WOLVERINE WORLD WIDE INC.
TEVA.N TEVA PHARMACEUTICAL INDUSTRIES LIMITED SPONSORED ADR
SHOO STEVEN MADDEN LTD.
RCKY ROCKY BRANDS
MAR MARRIOTT INTERNATIONAL INC. CLASS A
H HYATT HOTELS CORPORATION CLASS A
GPS GAP INC.
ANF ABERCROMBIE & FITCH CO. CLASS A
AEO AMERICAN EAGLE OUTFITTERS INC.
TARO TARO PHARMACEUTICAL INDUSTRIES LTD.
WEYS WEYCO GROUP INC.
HGV HILTON GRAND VACATIONS INC.
HLT HILTON WORLDWIDE HOLDINGS INC
AMRX AMNEAL PHARMACEUTICALS INC. CLASS A
HTHT HUAZHU GROUP LTD. SPONSORED ADR
VTRS VIATRIS INC.
IHG INTERCONTINENTAL HOTELS GROUP
02/27/24 February 27, 2024 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 48.00
TEVA.N Teva Pharmaceut...
RGEN Repligen Corpor... ... (+21)

Vermilion Compass: Weekly Equity Strategy

Upgrading Staples and Health Care to Market Weight As the saying goes, "sector rotation is the lifeblood of a bull market." That appears to be exactly what is going on as we kick off 2024. Leadership areas that have significantly outperformed since the October 2023 lows are starting to pull back rather hard -- and on above average volume. This includes areas such as Technology (XLK), semiconductors (SMH), software (IGV), and the ARKK, IPO, and BITQ ETFs. This tells us a pause/pullback is likely...

TEVA.N TEVA PHARMACEUTICAL INDUSTRIES LIMITED SPONSORED ADR
RGEN REPLIGEN CORPORATION
POST POST HOLDINGS INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MDLZ MONDELEZ INTERNATIONAL INC. CLASS A
KHC KRAFT HEINZ COMPANY
K KELLOGG COMPANY
ITCI INTRA-CELLULAR THERAPIES INC.
EXEL EXELIXIS INC.
CPB CAMPBELL SOUP COMPANY
CAG CONAGRA BRANDS INC.
TARO TARO PHARMACEUTICAL INDUSTRIES LTD.
IONS IONIS PHARMACEUTICALS INC.
THS TREEHOUSE FOODS INC.
SJM J.M. SMUCKER COMPANY
CRSP CRISPR THERAPEUTICS AG
NOMDN NOMAD FOODS LTD.
ASND ASCENDANT RESOURCES INC
AMRX AMNEAL PHARMACEUTICALS INC. CLASS A
PCVX VAXCYTE
VTRS VIATRIS INC.
01/03/24 January 3, 2024 1 EN
 PRESS RELEASE
Free
TARO Taro Pharmaceut...

Taro to Announce Full Year Results on May 17, 2018

HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for year ended March 31, 2018, on Thursday, May 17, 2018. The Company will conduct an earnings call at 8:00 am EDT on Friday, May 18, 2018, where senior management will discuss the Company’s performance and answer questions from participants. The release will be accessible on Taro’s website at www.taro.com. Earnings Call (8:00 am EDT on Friday, May 18, 2018)...

May 11, 2018 1 EN
 PRESS RELEASE
Free
TARO Taro Pharmaceut...

Taro Provides Results for December 31, 2017

HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and nine months ended December 31, 2017. Quarter ended December 31, 2017 Highlights ─ compared to December 31, 2016 Net sales of $155.5 million decreased $64.9 million, the result of continuing increased competition and the challenging pricing environment, particularly in the U.S.; despite an increase in overall volumes. ...

February 7, 2018 1 EN
 PRESS RELEASE
Free
TARO Taro Pharmaceut...

Taro to Announce Third Quarter Results on February 7, 2018

HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2017, after the close of market on Wednesday, February 7, 2018. The release will be accessible on Taro’s website at www.taro.com. About Taro Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, de...

January 31, 2018 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch